Govt engages pharmaceutical sector on policy, economic issues

February 04, 2026 (MLN): The government is engaging with the pharmaceutical sector to discuss policy, regulatory, and economic matters, with a focus on supporting growth, ensuring effective governance, and safeguarding patient interests. 

Discussions highlighted recent improvements in regulatory processes, digitalization, and progress toward international standards, as well as ways to boost investment, innovation, and export potential, said a press release issued.

Federal Minister for Finance and Revenue, Senator Muhammad Aurangzeb, met with a delegation of the Pharma Bureau, led by Chairman Syed Anis Ahmed. 

The delegation included Co-chair Ms. Erum Shakir Rahim, CEO of Haleon Pakistan Limited Mr. Qawi Naseer, CEO of Roche Pakistan Ms. Hafsa Shamsi, Mr. Sajjad Iftikhar, Ms. Andleeb Ahmed, and Executive Director Pharma Bureau Ms. Ayesha T. Haq. 

During the discussion, the delegation shared an overview of the sector’s performance, recent developments, and challenges, including pricing, regulatory processes, taxation, and investment facilitation.

Senator Aurangzeb acknowledged the pharmaceutical sector’s vital role in public health, employment generation, and economic activity. He briefed the participants on the government’s broader economic reform agenda, including measures for macroeconomic stabilization, tax rationalization, and promotion of sectoral growth. 

The Minister assured that the issues and proposals raised would be examined in coordination with relevant ministries and regulatory bodies, emphasizing the government’s commitment to continued engagement and stakeholder facilitation within the framework of national priorities.

The session concluded with a mutual understanding to maintain dialogue and cooperation, aiming to strengthen the pharmaceutical sector’s development, innovation, and contribution to the economy.

Copyright Mettis Link News